Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with

Tijana Krajisnik1, Hannes Olauson, Majd A I Mirza

  • 1Department of Medical Sciences, Uppsala University, Uppsala, Sweden. Tijana.Krajisnik@medsci.uu.se

Kidney International
|August 6, 2010
PubMed

Insights

Parathyroid glands show decreased fibroblast growth factor 23 (FGF23) receptors, Klotho and FGF receptor 1 (FGFR1), with worsening chronic kidney disease (CKD). This FGF23 resistance may explain secondary hyperparathyroidism in CKD patients.

Area of Science:

  • Endocrinology
  • Nephrology
  • Molecular Biology

Background:

  • Fibroblast growth factor 23 (FGF23) normally inhibits parathyroid hormone secretion.
  • Patients with chronic kidney disease (CKD) paradoxically develop secondary hyperparathyroidism despite elevated FGF23 levels, suggesting FGF23 resistance in parathyroid glands.

Purpose of the Study:

  • To investigate the expression and regulation of FGF23 receptors, Klotho and FGF receptor 1 (FGFR1), in parathyroid glands of patients with CKD.
  • To explore the potential mechanisms underlying parathyroid FGF23 resistance in CKD.

Main Methods:

  • Analysis of Klotho and FGFR1 mRNA expression in 88 hyperplastic parathyroid glands from 31 CKD patients.
  • In vitro studies using isolated bovine and human hyperplastic parathyroid cells treated with FGF23, calcium, vitamin D, phosphate, and parathyroid hormone.

Main Results:

  • Klotho and FGFR1 mRNA levels in parathyroid glands significantly decreased with declining glomerular filtration rate across CKD stages.
  • In vitro, FGF23 and calcium reduced Klotho expression in bovine cells, while vitamin D increased it.
  • FGFR1 expression was induced in human hyperplastic cells, and Klotho regulation differed between bovine and human cells.

Conclusions:

  • Parathyroid Klotho and FGFR1 expression decline with worsening renal function in CKD.
  • Altered mineral metabolism in CKD may contribute to decreased FGF23 receptor expression.
  • Reduced parathyroid Klotho and FGFR1 expression likely underlies FGF23 resistance observed in advanced CKD.

Related Concept Videos

The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Roles of Electrolytes: Calcium and Phosphate01:27

Roles of Electrolytes: Calcium and Phosphate

Calcium and phosphate are essential electrolytes in the human body, with calcium being the most abundant mineral. Around 99% of the body's calcium is stored in the skeleton and teeth, forming a crystal lattice of mineral salts in combination with phosphates. Calcium plays crucial roles in various bodily functions such as blood clotting, neurotransmitter release, muscle tone maintenance, and nervous and muscle tissue excitability.
The calcium concentration in blood plasma is primarily regulated...